Postoperative Cognitive Dysfunction Terminated Phase 4 Trials for Dexmedetomidine (DB00633)

IndicationStatusPhase
DBCOND0036861 (Postoperative Cognitive Dysfunction)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00455143Cognitive Protection - Dexmedetomidine and Cognitive ReserveTreatment